NL7404140A - - Google Patents

Info

Publication number
NL7404140A
NL7404140A NL7404140A NL7404140A NL7404140A NL 7404140 A NL7404140 A NL 7404140A NL 7404140 A NL7404140 A NL 7404140A NL 7404140 A NL7404140 A NL 7404140A NL 7404140 A NL7404140 A NL 7404140A
Authority
NL
Netherlands
Application number
NL7404140A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7404140A publication Critical patent/NL7404140A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/805Haemoglobins; Myoglobins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NL7404140A 1973-04-11 1974-03-27 NL7404140A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35022573A 1973-04-11 1973-04-11
US442276A US3925344A (en) 1973-04-11 1974-02-13 Plasma protein substitute

Publications (1)

Publication Number Publication Date
NL7404140A true NL7404140A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-10-15

Family

ID=26996533

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7404140A NL7404140A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-04-11 1974-03-27

Country Status (9)

Country Link
US (1) US3925344A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR7402876D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1033721A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2417619C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2225171B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1427903A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7404140A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE429195B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU629854A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2607706A1 (de) * 1975-02-27 1976-09-09 Alza Corp Wasserloesliches, polymerisiertes haemoglobin
US5854210A (en) * 1995-04-10 1998-12-29 Baxter International Inc. Use of cross-linked hemoglobin in treating subarachnoid hemorrhage

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4009267A (en) * 1975-09-09 1977-02-22 Diagnostic Data, Inc. Cross-linked orgotein
CA1055932A (en) * 1975-10-22 1979-06-05 Hematech Inc. Blood substitute based on hemoglobin
US4427416A (en) 1980-10-10 1984-01-24 Duke University Processes for extracting oxygen from fluids using immobilized hemoglobin
US4343715A (en) * 1980-10-10 1982-08-10 Duke University Immobilized hemoglobin, and processes for extracting oxygen from fluids using the same
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
DE3320752A1 (de) * 1983-06-09 1984-12-13 Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
DE3340592A1 (de) * 1983-11-10 1985-05-23 B. Braun Melsungen Ag, 3508 Melsungen Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
US5753616A (en) * 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5955581A (en) * 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
EP0302734B1 (en) * 1987-08-06 1993-10-20 Oxygenetics Inc. Continuous processes for modifying biologically active materials and the products therefrom
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
EP0559655B1 (en) * 1990-11-29 1995-03-15 The Upjohn Company Imidoester cross-linked hemoglobin compositions
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
DE4418973A1 (de) * 1994-05-31 1995-12-14 Barnikol Wolfgang Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
EP0854151A1 (de) 1997-01-20 1998-07-22 SanguiBioTech AG Verfahren zur Gewinnung einheitlicher Fraktionen hyperpolymerer Hämoglobine
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US6054427A (en) * 1997-02-28 2000-04-25 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
CA2233725A1 (en) * 1998-03-31 1999-09-30 Hemosol Inc. Hemoglobin-hydroxyethyl starch complexes
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
WO2003059287A2 (en) * 2002-01-11 2003-07-24 Sangart, Inc. Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
US20030153491A1 (en) 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
EP1894573A3 (en) 2002-01-11 2013-06-12 Sangart, Inc. Methods and compositions for oxygen transport comprising a high oxygen affinity
EP1469811A4 (en) * 2002-01-11 2006-01-04 Sangart Inc METHOD AND COMPOSITIONS FOR OXYGEN TRANSPORT WITH MODIFIED HEMOGLOBIN IN PLASMA
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US7135554B1 (en) * 2004-01-27 2006-11-14 Biopure Corporation Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
ATE478674T1 (de) * 2004-08-31 2010-09-15 Sangart Inc Verfahren zur verbesserung der hämodynamischen stabilität mit sauerstoff-tragenden zusammensetzungen
US8273857B2 (en) * 2009-09-22 2012-09-25 Jen-Chang Hsia Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
JP6807740B2 (ja) 2013-05-03 2021-01-06 ワシントン・ユニバーシティWashington University 血液代用組成物及びその使用方法
RU2749266C1 (ru) * 2020-02-10 2021-06-07 Богдан Иванович Асатуров Способ получения биоплазмозаменителя гемодинамического действия

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE945650C (de) * 1952-01-24 1956-07-12 Charles B Knox Gelatine Co Inc Verfahren zur Herstellung von als Blutplasmastreckmittel dienenden serologisch vertraeglichen Proteinderivaten
SE343210B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1967-12-20 1972-03-06 Pharmacia Ab

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2607706A1 (de) * 1975-02-27 1976-09-09 Alza Corp Wasserloesliches, polymerisiertes haemoglobin
US5854210A (en) * 1995-04-10 1998-12-29 Baxter International Inc. Use of cross-linked hemoglobin in treating subarachnoid hemorrhage

Also Published As

Publication number Publication date
SE429195B (sv) 1983-08-22
FR2225171A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-11-08
GB1427903A (en) 1976-03-10
FR2225171B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-08-12
US3925344A (en) 1975-12-09
SU629854A3 (ru) 1978-10-25
DE2417619C2 (de) 1986-10-23
BR7402876D0 (pt) 1974-12-03
DE2417619A1 (de) 1974-10-31
CA1033721A (en) 1978-06-27

Similar Documents

Publication Publication Date Title
AR201758A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU465372B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2225171B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201235Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201231Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU465453B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU450229B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201229Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR199451A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201432A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR210729A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR197627A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR196382A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR200256A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR200885A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU447540B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU461342B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1891376A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR196212Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH563876A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH566894A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH564393A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH563892A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU479420A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH563627A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed